General Information
Product name
Ciprofloxacin Ophthalmic Solution, USP 0.3%
Manufacturer Name
Akorn Incorporated
Icons in SDS
Company Information
company name
Akorn Incorporated
e-mail address of the competent person responsible for the Safety Data Sheet
customer.service@akorn.com
Section 2
Health hazards
Carcinogenicity No Eye May irritate Skin Ciprofloxacin should be discontinued at the first appearance of a skin rash or any other sign of hypersensitivity reaction Ingestion No data Inhalation May irritate the respiratory system
Potential chronic health
Ciprofloxacin and related drugs have been shown to cause arthropathy in immature animals of most species tested following oral administration. However, a one‐month topical ocular study using immature Beagle dogs did not demonstrate any articular lesions Target Organs: No data Section 3 ‐ PHYSICAL AND CHEMICAL CHARACTERISTICS Appearance Boiling Point (C°) Clear, pale yellow to yellow solution Not Established Vapor Pressure (mmHg at 20°C) Vapor Density (g/m³) Viscosity Osmolality pH Specific Gravity Solubility in Water Latex Free: Not Established ~ 300 mOsm/Kg 3.5 to 5.5 1.018 g/mL Soluble Yes Section 4 ‐ FIRE AND EXPLOSION HAZARD DATA Flammable Properties Flash point Not Established Method Not Established Extinguishing Media Dry chemical, carbon dioxide, halon, water spray or fog, and foam on surrounding materials
